Portfolio Update

RNS Number : 0929I

Intl. Biotechnology Trust PLC

14 June 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 May 2017

Net Assets	£227m
Net Assets per share	603p
Share price	572p
Total value of unquoted investments	£23m
Total number of portfolio companies	91
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	7.6
Regeneron	7.6
Genmab	5.6
Vertex	5.5
Biogen	5.2
Shire	4.0
Alexion	3.6
Incyte	3.4
Aerie	2.9
Biomarin	2.8
	-----------
Total	48.2

Geographical Allocation	% NAV
US & Canada	80
Europe & UK	20
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	90
Unquoted	10
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	53
Mid Cap =USD1-10BN	22
Small Cap <USD1BN	25
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	34
Orphan	13
CNS	11
Ophthalmology	11
Inflammation	7
Medtech	2
Other	22
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

14 JUNE 2017

 

END

 

 

PFUBDGDLLDBBGRS